Get started
Award

2024A1515012581

Funded outputs count: 9
Funder award ID: 2024A1515012581
OpenAlex ID: G4580098176
Systemic treatment patterns and clinical outcomes in hepatocellular carcinoma: A multicenter real-world study from China (STAR-HCC)
2026 · Benyi He, Wenmin Liao, et al. · JHEP Reports
A prognostic model combining hilar lymph node metastasis and preoperative anemia to predict outcomes after curative resection of intrahepatic cholangiocarcinoma
2026 · Min Deng, Benyi He, et al. · BMC Cancer
214P Continuation of immunotherapy versus discontinuation after failure of first-line transarterial therapy combined with tyrosine kinase inhibitors and immunotherapy for advanced hepatocellular carcinoma
2026 · B. He, M. Deng, et al. · Annals of Oncology
206P Adjuvant systemic therapy versus active surveillance after conversion resection for hepatocellular carcinoma
2026 · B. He, Z. Zheng, et al. · Annals of Oncology
PDF
Adjuvant systemic therapy versus active surveillance after resection following conversion therapy for hepatocellular carcinoma: a propensity score matched study
2026 · Benyi He, Zehao Zheng, et al. · BMC Medicine · 1
HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial
2026 · Shao-Hua Li, Zhi-Jun Zuo, et al. · Signal Transduction and Targeted Therapy
PDF
DLGAP5 regulates malignancy and lenvatinib sensitivity of hepatocellular carcinoma through AKT/mTOR/NF-κB pathway
2026 · Benyi He, Min Deng, et al. · European journal of medical research
364P Systemic treatment patterns and survival outcomes for hepatocellular carcinoma – A multicenter real-world study
2025 · B. He, W. Liao, et al. · Annals of Oncology
WITHDRAWN: 105eP A prognostic nomogram for intrahepatic cholangiocarcinoma treated with combined HAIC, targeted therapy and immune checkpoint inhibitors: A multicenter retrospective study
2025 · X. Xiong, W. Dai, et al. · Annals of Oncology
Year
Topic